The closing price of U.S. Physical Therapy Inc. (NYSE: USPH) was $97.16 for the day, up 0.67% from the previous closing price of $96.51. In other words, the price has increased by $+0.65 from its previous closing price. On the day, 1477895 shares were traded. USPH stock price reached its highest trading level at $97.42 during the session, while it also had its lowest trading level at $92.58.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
Ratios:
Our analysis of USPH’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.30 and its Current Ratio is at 1.30. In the meantime, Its Debt-to-Equity ratio is 0.60 whereas as Long-Term Debt/Eq ratio is at 0.57.
Upgrades & Downgrades
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 15 when Harris Bernard A Jr sold 5,000 shares for $92.50 per share. The transaction valued at 462,500 led to the insider holds 15,702 shares of the business.
HENDRICKSON CAREY P sold 471 shares of USPH for $45,122 on Mar 13. The Chief Financial Officer now owns 14,886 shares after completing the transaction at $95.80 per share. On Mar 03, another insider, Williams Eric Joseph, who serves as the Co-Chief Operations Officer of the company, sold 1,150 shares for $101.66 each. As a result, the insider received 116,905 and left with 12,714 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, USPH now has a Market Capitalization of 1.49B and an Enterprise Value of 1.75B. As of this moment, U.S.’s Price-to-Earnings (P/E) ratio for their current fiscal year is 45.06, and their Forward P/E ratio for the next fiscal year is 30.96. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.51. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.20 while its Price-to-Book (P/B) ratio in mrq is 3.98. Its current Enterprise Value per Revenue stands at 3.08 whereas that against EBITDA is 22.78.
Stock Price History:
Over the past 52 weeks, USPH has reached a high of $131.50, while it has fallen to a 52-week low of $73.30. The 50-Day Moving Average of the stock is 103.42, while the 200-Day Moving Average is calculated to be 91.06.
Shares Statistics:
USPH traded an average of 78.55K shares per day over the past three months and 235.67k shares per day over the past ten days. A total of 13.03M shares are outstanding, with a floating share count of 12.75M. Insiders hold about 1.40% of the company’s shares, while institutions hold 106.96% stake in the company. Shares short for USPH as of Apr 27, 2023 were 770.1k with a Short Ratio of 0.75M, compared to 721.86k on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 5.90% and a Short% of Float of 7.15%.
Dividends & Splits
With its trailing 12-month dividend rate of 1.66, USPH has a forward annual dividend rate of 1.68. Against a Trailing Annual Dividend Yield of 1.72%, it implies a Forward Annual Dividend Yield of 1.57%. The stock’s 5-year Average Dividend Yield is 1.09. The current Payout Ratio is 72.86% for USPH, which recently paid a dividend on Jun 08, 2023 with an ex-dividend date of May 16, 2023. Stock splits for the company last occurred on Jun 28, 2001 when the company split stock in a 3:2 ratio.
Earnings Estimates
The firm’s stock currently is rated by 4 analysts. On average, analysts expect EPS of $0.75 for the current quarter, with a high estimate of $0.82 and a low estimate of $0.71, while EPS last year was $0.9. The consensus estimate for the next quarter is $0.63, with high estimates of $0.71 and low estimates of $0.56.
Analysts are recommending an EPS of between $2.65 and $2.61 for the fiscal current year, implying an average EPS of $2.63. EPS for the following year is $3.14, with 4 analysts recommending between $3.37 and $3.02.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 4 analysts. It ranges from a high estimate of $156.3M to a low estimate of $148.8M. As of the current estimate, U.S. Physical Therapy Inc.’s year-ago sales were $140.66M, an estimated increase of 7.50% from the year-ago figure. For the next quarter, 4 analysts are estimating revenue of $148.35M, an increase of 6.30% less than the figure of $7.50% in the same quarter last year. There is a high estimate of $153.4M for the next quarter, whereas the lowest estimate is $145.1M.
A total of 4 analysts have provided revenue estimates for USPH’s current fiscal year. The highest revenue estimate was $609.5M, while the lowest revenue estimate was $589.4M, resulting in an average revenue estimate of $597.72M. In the same quarter a year ago, actual revenue was $553.14M, up 8.10% from the average estimate. Based on 4 analysts’ estimates, the company’s revenue will be $624.86M in the next fiscal year. The high estimate is $641.2M and the low estimate is $604.6M. The average revenue growth estimate for next year is up 4.50% from the average revenue estimate for this year.
